468 related articles for article (PubMed ID: 20412744)
41. The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30
Hutchison T; Malu A; Yapindi L; Bergeson R; Peck K; Romeo M; Harrod C; Pope J; Smitherman L; Gwinn W; Ratner L; Yates C; Harrod R
Virology; 2018 Jul; 520():39-58. PubMed ID: 29777913
[TBL] [Abstract][Full Text] [Related]
42. Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related Diseases.
Mesnard JM; Barbeau B; Césaire R; Péloponèse JM
Viruses; 2015 Dec; 7(12):6490-505. PubMed ID: 26690203
[TBL] [Abstract][Full Text] [Related]
43. HTLV-1 bZIP factor gene: Its roles in HTLV-1 pathogenesis.
Matsuoka M
Mol Aspects Med; 2010 Oct; 31(5):359-66. PubMed ID: 20599553
[TBL] [Abstract][Full Text] [Related]
44. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.
Miyazaki M; Yasunaga J; Taniguchi Y; Tamiya S; Nakahata T; Matsuoka M
J Virol; 2007 Jun; 81(11):5714-23. PubMed ID: 17344291
[TBL] [Abstract][Full Text] [Related]
45. The Role of HBZ in HTLV-1-Induced Oncogenesis.
Zhao T
Viruses; 2016 Feb; 8(2):. PubMed ID: 26848677
[TBL] [Abstract][Full Text] [Related]
46. [HTLV-1 pathogenesis mediated by HTLV-1 bZIP factor].
Satou Y
Uirusu; 2012 Jun; 62(1):113-20. PubMed ID: 23189831
[TBL] [Abstract][Full Text] [Related]
47. The bZIP transcription factor ATFx binds human T-cell leukemia virus type 1 (HTLV-1) Tax and represses HTLV-1 long terminal repeat-mediated transcription.
Forgacs E; Gupta SK; Kerry JA; Semmes OJ
J Virol; 2005 Jun; 79(11):6932-9. PubMed ID: 15890932
[TBL] [Abstract][Full Text] [Related]
48. Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1.
Wright DG; Marchal C; Hoang K; Ankney JA; Nguyen ST; Rushing AW; Polakowski N; Miotto B; Lemasson I
Oncotarget; 2016 Jan; 7(2):1687-706. PubMed ID: 26625199
[TBL] [Abstract][Full Text] [Related]
49. Permissive Sense and Antisense Transcription from the 5' and 3' Long Terminal Repeats of Human T-Cell Leukemia Virus Type 1.
Laverdure S; Polakowski N; Hoang K; Lemasson I
J Virol; 2016 Jan; 90(7):3600-10. PubMed ID: 26792732
[TBL] [Abstract][Full Text] [Related]
50. The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA.
Choudhary G; Ratner L
Virology; 2011 Feb; 410(2):307-15. PubMed ID: 21176937
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.
Arnold J; Yamamoto B; Li M; Phipps AJ; Younis I; Lairmore MD; Green PL
Blood; 2006 May; 107(10):3976-82. PubMed ID: 16424388
[TBL] [Abstract][Full Text] [Related]
52. Tax abolishes histone H1 repression of p300 acetyltransferase activity at the human T-cell leukemia virus type 1 promoter.
Konesky KL; Nyborg JK; Laybourn PJ
J Virol; 2006 Nov; 80(21):10542-53. PubMed ID: 16943293
[TBL] [Abstract][Full Text] [Related]
53. HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation.
Sugata K; Yasunaga J; Kinosada H; Mitobe Y; Furuta R; Mahgoub M; Onishi C; Nakashima K; Ohshima K; Matsuoka M
Cancer Res; 2016 Sep; 76(17):5068-79. PubMed ID: 27402079
[TBL] [Abstract][Full Text] [Related]
54. Leukaemogenic mechanism of human T-cell leukaemia virus type I.
Yasunaga J; Matsuoka M
Rev Med Virol; 2007; 17(5):301-11. PubMed ID: 17621367
[TBL] [Abstract][Full Text] [Related]
55. HTLV-1 basic leucine-zipper factor, HBZ, interacts with MafB and suppresses transcription through a Maf recognition element.
Ohshima T; Mukai R; Nakahara N; Matsumoto J; Isono O; Kobayashi Y; Takahashi S; Shimotohno K
J Cell Biochem; 2010 Sep; 111(1):187-94. PubMed ID: 20506502
[TBL] [Abstract][Full Text] [Related]
56. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo.
Satou Y; Yasunaga J; Zhao T; Yoshida M; Miyazato P; Takai K; Shimizu K; Ohshima K; Green PL; Ohkura N; Yamaguchi T; Ono M; Sakaguchi S; Matsuoka M
PLoS Pathog; 2011 Feb; 7(2):e1001274. PubMed ID: 21347344
[TBL] [Abstract][Full Text] [Related]
57. Role of the HTLV-1 viral factors in the induction of apoptosis.
Karimi M; Mohammadi H; Hemmatzadeh M; Mohammadi A; Rafatpanah H; Baradaran B
Biomed Pharmacother; 2017 Jan; 85():334-347. PubMed ID: 27887847
[TBL] [Abstract][Full Text] [Related]
58. Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.
Naito T; Yasunaga JI; Mitobe Y; Shirai K; Sejima H; Ushirogawa H; Tanaka Y; Nakamura T; Hanada K; Fujii M; Matsuoka M; Saito M
Retrovirology; 2018 Nov; 15(1):72. PubMed ID: 30400920
[TBL] [Abstract][Full Text] [Related]
59. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.
Matsuoka M; Jeang KT
Nat Rev Cancer; 2007 Apr; 7(4):270-80. PubMed ID: 17384582
[TBL] [Abstract][Full Text] [Related]
60. Making sense out of antisense transcription in human T-cell lymphotropic viruses (HTLVs).
Barbeau B; Mesnard JM
Viruses; 2011 May; 3(5):456-68. PubMed ID: 21994742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
